PCAT-1, a long noncoding RNA, regulates BRCA2 and controls homologous recombination in cancer

239Citations
Citations of this article
176Readers
Mendeley users who have this article in their library.

Abstract

Impairment of double-stranded DNA break (DSB) repair is essential to many cancers. However, although mutations in DSB repair proteins are common in hereditary cancers, mechanisms of impaired DSB repair in sporadic cancers remain incompletely understood. Here, we describe the first role for a long noncoding RNA (lncRNA) in DSB repair in prostate cancer. We identify PCAT-1, a prostate cancer outlier lncRNA, which regulates cell response to genotoxic stress. PCAT-1 expression produces a functional deficiency in homologous recombination through its repression of the BRCA2 tumor suppressor, which, in turn, imparts a high sensitivity to smallmolecule inhibitors of PARP1. These effects reflected a posttranscriptional repression of the BRCA2 30UTR by PCAT-1. Our observations thus offer a novel mechanism of "BRCAness" in sporadic cancers.©2014 American Association for Cancer Research.

Cite

CITATION STYLE

APA

Prensner, J. R., Chen, W., Iyer, M. K., Cao, Q., Ma, T., Han, S., … Feng, F. Y. (2014). PCAT-1, a long noncoding RNA, regulates BRCA2 and controls homologous recombination in cancer. Cancer Research, 74(6), 1651–1660. https://doi.org/10.1158/0008-5472.CAN-13-3159

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free